SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Yared Nadim

(Last) (First) (Middle)
9201 W BROADWAY AVE
#650

(Street)
MINNEAPOLIS MN 55445

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2021
3. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,585 I By trust for children
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (1) 08/06/2025 Common Stock 31,037 $0.237 D
Stock Option (1) 08/06/2025 Common Stock 3,792 $0.237 D
Stock Option (1) 08/06/2025 Common Stock 5,916 $0.237 D
Stock Option (1) 08/06/2025 Common Stock 12,641 $0.237 D
Stock Option (1) 08/06/2025 Common Stock 11,377 $0.237 D
Stock Option (1) 11/11/2023 Common Stock 15,745 $0.237 D
Stock Option (1) 09/10/2024 Common Stock 5,057 $0.237 D
Stock Option (1) 06/30/2025 Common Stock 10,114 $0.237 D
Stock Option (2) 06/30/2025 Common Stock 10,114 $0.237 D
Stock Option (1) 09/27/2026 Common Stock 37,093 $0.237 D
Stock Option (3) 02/15/2028 Common Stock 70,041 $0.237 D
Stock Option (4) 02/15/2028 Common Stock 76,615 $0.237 D
Stock Option (5) 07/23/2029 Common Stock 88,499 $3.955 D
Stock Option (1) 09/30/2030 Common Stock 50,900 $4.35 D
Stock Option (6) 09/30/2030 Common Stock 50,184 $4.35 D
Stock Option (7) 09/30/2030 Common Stock 45,635 $4.35 D
Stock Option (8) 09/30/2030 Common Stock 44,859 $4.35 D
Stock Option (9) 02/03/2031 Common Stock 50,570 $7.119 D
Explanation of Responses:
1. Fully exercisable.
2. Fully exercisable, subject to Issuer's right to repurchase shares at exercise price, which repurchase right lapses with respect to 25% of the shares on the first anniversary of the date on which a certain revenue metric is achieved and with respect to the 1/48th of the shares on each month thereafter.
3. Fully exercisable, subject to Issuer's right to repurchase shares at the exercise price, which repurchase right lapsed with respect to 25% of the shares on February 16, 2019 and lapses as to 1/48th of the shares each month thereafter.
4. Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.
5. Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares on each month thereafter
6. Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
7. Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
8. Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares on each month thereafter.
9. Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares on each month thereafter.
/s/ Amy C. Seidel, Attorney-in-Fact 06/29/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.